Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
4.280
-0.270 (-5.93%)
Aug 14, 2025, 11:46 AM - Market open
Cryo-Cell International Cash Flow Statement
Financials in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 31, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | Nov '20 Nov 30, 2020 | 2015 - 2019 |
| Net Income | -0.17 | 0.4 | -9.52 | 2.77 | 2.08 | 3.62 | Upgrade
|
| Depreciation & Amortization | 1.36 | 1.02 | 1.71 | 1.81 | 1.33 | 0.64 | Upgrade
|
| Other Amortization | 0.02 | 0.02 | 0.02 | 0.02 | 0.06 | 0.09 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.05 | - | - | -0.41 | 0.02 | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 13.11 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.13 | -0.87 | -0.17 | 0.04 | 0.01 | 0.01 | Upgrade
|
| Stock-Based Compensation | 0.63 | 0.78 | 0.82 | 0.46 | 0.3 | 0.62 | Upgrade
|
| Provision & Write-off of Bad Debts | 1.07 | 1.27 | 1.04 | 0.93 | 0.54 | 0.6 | Upgrade
|
| Other Operating Activities | -0.3 | -0.31 | -4.06 | -1.3 | -1.26 | -0.87 | Upgrade
|
| Change in Accounts Receivable | -1.17 | -2 | -1.57 | -1.72 | 0.53 | -0.83 | Upgrade
|
| Change in Inventory | 0.36 | 0.43 | 0.36 | 0.49 | 0.21 | 0.45 | Upgrade
|
| Change in Accounts Payable | 0.55 | -0.42 | 0.69 | 0.12 | 0.53 | -0.41 | Upgrade
|
| Change in Unearned Revenue | 4.89 | 5.45 | 5.3 | 4.95 | 4.25 | 3.88 | Upgrade
|
| Change in Other Net Operating Assets | -0.91 | 0.24 | 1.2 | 0.41 | -0.67 | 0.67 | Upgrade
|
| Operating Cash Flow | 6.26 | 6.01 | 8.92 | 8.57 | 7.93 | 8.47 | Upgrade
|
| Operating Cash Flow Growth | -6.68% | -32.61% | 4.05% | 8.16% | -6.38% | 34.50% | Upgrade
|
| Capital Expenditures | -0.32 | -2.4 | -6.84 | -12.17 | -1.83 | -0.1 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.12 | - | - | 1.87 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.27 | -1.2 | -0.8 | -5 | -5.12 | -0.35 | Upgrade
|
| Investment in Securities | -3.1 | -1.27 | -0.51 | 0.02 | - | 0.81 | Upgrade
|
| Investing Cash Flow | -3.57 | -4.88 | -8.14 | -15.28 | -6.95 | 0.36 | Upgrade
|
| Short-Term Debt Issued | - | 5.22 | 0.95 | 7.67 | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | 8.96 | - | - | Upgrade
|
| Total Debt Issued | 8.82 | 5.22 | 0.95 | 16.63 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -2.92 | -2 | -5.4 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.14 | -0.16 | -1.95 | -4.1 | -3.1 | Upgrade
|
| Total Debt Repaid | -6.56 | -3.06 | -2.16 | -7.35 | -4.1 | -3.1 | Upgrade
|
| Net Debt Issued (Repaid) | 2.26 | 2.16 | -1.21 | 9.29 | -4.1 | -3.1 | Upgrade
|
| Issuance of Common Stock | 0.08 | 0.08 | - | 0.55 | 1.28 | 0.04 | Upgrade
|
| Repurchase of Common Stock | -0.11 | -1.42 | -0.8 | -1.82 | -0.25 | - | Upgrade
|
| Common Dividends Paid | -5.25 | -2.02 | - | - | - | - | Upgrade
|
| Other Financing Activities | - | 0.23 | -0.07 | -0.2 | - | -1.95 | Upgrade
|
| Financing Cash Flow | -3.02 | -0.98 | -2.07 | 0.15 | -3.07 | -5 | Upgrade
|
| Net Cash Flow | -0.33 | 0.15 | -1.3 | -6.56 | -2.1 | 3.82 | Upgrade
|
| Free Cash Flow | 5.94 | 3.61 | 2.08 | -3.6 | 6.09 | 8.37 | Upgrade
|
| Free Cash Flow Growth | - | 73.36% | - | - | -27.19% | 48.54% | Upgrade
|
| Free Cash Flow Margin | 18.56% | 11.28% | 6.64% | -11.85% | 21.09% | 26.86% | Upgrade
|
| Free Cash Flow Per Share | 0.73 | 0.44 | 0.25 | -0.42 | 0.73 | 1.03 | Upgrade
|
| Cash Interest Paid | 2.01 | 1.98 | 1.81 | 1.26 | 1.04 | 0.31 | Upgrade
|
| Cash Income Tax Paid | 2.96 | 2.72 | 1.82 | 1.57 | 3.53 | 1.88 | Upgrade
|
| Levered Free Cash Flow | 2.09 | -3.05 | -3.99 | -15.31 | 2.38 | 4.05 | Upgrade
|
| Unlevered Free Cash Flow | 3.53 | -1.91 | -3.24 | -14.66 | 3.19 | 4.93 | Upgrade
|
| Change in Working Capital | 3.72 | 3.7 | 5.99 | 4.25 | 4.86 | 3.76 | Upgrade
|
Updated Apr 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.